Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 20,537 |
|
|||||
| News | - | ||||||
| Day High | 3.49 | Low High |
|||||
| Day Low | 3.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NeuroBo Pharmaceuticals Inc | NRBO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.07 | -2.03% | 3.37 | 16:02:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.44 | 3.26 | 3.49 | 3.37 | 3.44 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 193 | 20,537 | $ 3.39 | $ 69,629 | - | 2.8888 - 6.7499 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 80 | $ 3.28 | USD |
NeuroBo Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.4M | 4.85M | - | 0 | -12.47M | -2.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NeuroBo Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NRBO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.58 | 3.95 | 3.26 | 3.54 | 29,143 | -0.21 | -5.87% |
| 1 Month | 4.60 | 4.73 | 3.26 | 3.92 | 30,563 | -1.23 | -26.74% |
| 3 Months | 3.09 | 6.7499 | 3.00 | 5.43 | 1,437,067 | 0.28 | 9.06% |
| 6 Months | 3.60 | 6.7499 | 2.90 | 5.32 | 709,215 | -0.23 | -6.39% |
| 1 Year | 5.9136 | 6.7499 | 2.8888 | 5.02 | 503,574 | -2.54 | -43.01% |
| 3 Years | 777.60 | 1,576.80 | 2.8888 | 260.65 | 1,036,618 | -774.23 | -99.57% |
| 5 Years | 2,196.00 | 7,200.00 | 2.8888 | 321.79 | 756,673 | -2,192.63 | -99.85% |
NeuroBo Pharmaceuticals Description
| NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19. ANA001 is being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the USA. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments. |
